Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-709-6 | CAS number: 31570-04-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Neurotoxicity
Administrative data
Description of key information
not neurotoxic to the domestic fowl
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Link to relevant study records
- Endpoint:
- neurotoxicity: acute oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 418 (Delayed Neurotoxicity of Organophosphorus Substances Following Acute Exposure)
- Deviations:
- yes
- Remarks:
- No negative control. No preliminary study. No body weight or biochemical parameters measured.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- hen
- Strain:
- other: White Leghorn strain
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: VALO" SPF, Lohmann GmbH., Cuxhaven, Germany
- Age at study initiation: 12 months old
- Weight at study initiation: 1.1-2.1 kg- Housing: kept in groups of 5 or 6 (5 females, or 3 males, 3 females) in polyester cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + /-1°C
- Humidity (%): 5 5 +/- 5 %
- Photoperiod (hrs dark / hrs light): 10 hours light cycle - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Duration of treatment / exposure:
- Treatment was performed orally by gavage. The test substance was administered twice, initially and after 21 days. TOCP was administered once.
- Frequency of treatment:
- Treatment was performed orally by gavage. The test substance was administered twice, initially and after 21 days. TOCP was administered once.
- Dose / conc.:
- 2 150 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 6 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 2150 mg/kg 20 female 6000 mg/kg 30 female
- Control animals:
- no
- Details on study design:
- Fowls treated with the test substance were observed during a 50-day observation period and those treated with TOCP during a 21-day period.
- Observations and clinical examinations performed and frequency:
- acute nor delayed systemic symptoms
- Details on results:
- Signs of acute and delayed toxicityTest substance: Neither acute nor delayed systemic symptoms were observed after the first and second treatinent during the 50 observation days. TOCP; Only slight ataxy and sedation was observed during 2 to 7 days after treatment in those birds that received 600 up to 2150 mg/kg. VJithin 8 to 13 days after administration the male and female birds of all treated groups showed progressive ataxy and deterioration of reflexes, as well as sedation and partially ventral or curved position. These symptoms were more pronounced in the higher dose groups. The male birds of all groups seemed to be less affected than the females.
- Dose descriptor:
- NOAEL
- Effect level:
- > 6 000 mg/kg bw/day
- Remarks on result:
- other:
- Conclusions:
- The acute oral LD50 of the test substance in hens was found to be greater than 10'000 mg/kg. Doses of 2150 and 6000 mg/kg were administered in the neurotoxicity assay.The oral administration of 2150 and 6000 mg/kg of the test substance dosed twice at an interval of 21 days revealed no toxic symptoms. Histopathological lesions of the nervous system were absent and there was no evidence that delayed neurotoxicity was produced. Therefore, it was concluded that the test substance did not cause neurotoxicity in hens, such as observed with TOCP* included in the test as the reference compound ("positive control").
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 6 000 mg/kg bw/day
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The substance was applied to a total of 50 hens of the White Leghorn strain. The treatment by gavage was performed twice at an interval of 21 days with doses of 2150 (20 hens) and 6000 mg/kg bw (30 hens).
Neither acute nor delayed toxic symptoms were recorded during the 50-day observation period. Histopathological lesions of the nervous system were absent and there was no evidence for delayed neurotoxicity.
Justification for classification or non-classification
There are conclusive but not sufficient data for classification of the test substance with regard to neurotoxicity. The substance is not classified for this endpoint in accordance to the CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
